This can make it difficult to get coverage for GLP-1 medications unless they are prescribed for another condition, such as diabetes
Previous research suggests that glucose-lowering drugs (GLDs), including GLP-1 receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors, may offer a neuroprotective effect against dementia, but this association has yet to be confirmed
For patients in this category, nutritionists will use more standard dietary counseling and weight loss approaches
1 This level of weight loss supports survodutides potential as a clinically meaningful treatment option for people living with obesity or overweight
You might look at your body fat percentage, body measurements, or how your clothes fit
But how does this drug affect cortisol levels in your body